Mirion Announces Departure of Medical Group President
18 Octobre 2023 - 10:05PM
Business Wire
Mirion’s Chief Executive Officer, Thomas Logan,
will reassume responsibilities of Medical Group President until
permanent successor is named
Mirion (“we” or the “company”) (NYSE: MIR), a global provider of
radiation detection, measurement, analysis and monitoring solutions
to the medical, nuclear, defense, and research end markets, today
announced that Michael Rossi has informed the Company of his
decision to resign as Medical Group President, effective November
1, 2023, in order to assume a CEO role at another public
company.
Mirion’s Chief Executive Officer, Thomas Logan, will reassume
the responsibilities of Medical Group President until a permanent
successor is named. Mr. Logan had previously served as acting
Medical Group President through much of 2022.
“Mike has been a valued member of the Mirion executive team for
the last year, and we are grateful for his contributions,” said Mr.
Logan. “All of us at Mirion wish Mike well as he takes this next
step in his career as a public company CEO.”
About Mirion
Mirion (NYSE: MIR) is a global leader in radiation safety,
science and medicine, empowering innovations that deliver vital
protection while harnessing the transformative potential of
ionizing radiation across a diversity of end markets. The Mirion
Technologies group provides proven radiation safety technologies
that operate with precision – for essential work within R&D
labs, critical nuclear facilities, and on the front lines. The
Mirion Medical group solutions help enhance the delivery and ensure
safety in healthcare, powering the fields of Nuclear Medicine,
Radiation Therapy QA, Occupational Dosimetry, and Diagnostic
Imaging. Headquartered in Atlanta (GA – USA), Mirion employs
approximately 2,700 people and operates in 12 countries. Learn more
at mirion.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20231018343266/en/
For investor inquiries: Jerry Estes ir@mirion.com
For media inquiries: Erin Schesny media@mirion.com
Mirion Technologies (NYSE:MIR)
Graphique Historique de l'Action
De Oct 2024 à Nov 2024
Mirion Technologies (NYSE:MIR)
Graphique Historique de l'Action
De Nov 2023 à Nov 2024